These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 32226547)

  • 41. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
    Bonavida B; Baritaki S
    Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
    Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B
    Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Transcription Factor YY1 in the Biology of Cancer.
    Agarwal N; Theodorescu D
    Crit Rev Oncog; 2017; 22(1-2):13-21. PubMed ID: 29604933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
    Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B
    J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Yin and Yang of YY1 in the nervous system.
    He Y; Casaccia-Bonnefil P
    J Neurochem; 2008 Aug; 106(4):1493-502. PubMed ID: 18485096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The YY1-CPT1C signaling axis modulates the proliferation and metabolism of pancreatic tumor cells under hypoxia.
    Zhou Y; Chen Y; Zhao P; Xian T; Gao Y; Fan S; Fang JH; Huang M; Bi H
    Biochem Pharmacol; 2024 Sep; 227():116422. PubMed ID: 38996932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The involvement of the transcription factor Yin Yang 1 in cancer development and progression.
    Castellano G; Torrisi E; Ligresti G; Malaponte G; Militello L; Russo AE; McCubrey JA; Canevari S; Libra M
    Cell Cycle; 2009 May; 8(9):1367-72. PubMed ID: 19342874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yin Yang I as an Epimodulator of miRNAs in the Metastatic Cascade.
    Ruosi C; Colella G; Fazioli F; Miceli R; Gallo M; Di Salvatore MG; Cimmino A; de Nigris F
    Crit Rev Oncog; 2017; 22(1-2):99-107. PubMed ID: 29604939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcription factor YY1 expression in human gastrointestinal cancer cells.
    Chinnappan D; Xiao D; Ratnasari A; Andry C; King TC; Weber HC
    Int J Oncol; 2009 May; 34(5):1417-23. PubMed ID: 19360355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression.
    Affar el B; Gay F; Shi Y; Liu H; Huarte M; Wu S; Collins T; Li E; Shi Y
    Mol Cell Biol; 2006 May; 26(9):3565-81. PubMed ID: 16611997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Yin Yang 1: a multifaceted protein beyond a transcription factor.
    Deng Z; Cao P; Wan MM; Sui G
    Transcription; 2010; 1(2):81-4. PubMed ID: 21326896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets.
    Fu X; Ji F; He Q; Qiu X
    J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
    Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
    Begon DY; Delacroix L; Vernimmen D; Jackers P; Winkler R
    J Biol Chem; 2005 Jul; 280(26):24428-34. PubMed ID: 15870067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.
    Hoxha S; Shepard A; Troutman S; Diao H; Doherty JR; Janiszewska M; Witwicki RM; Pipkin ME; Ja WW; Kareta MS; Kissil JL
    Cancer Res; 2020 Jun; 80(12):2512-2522. PubMed ID: 32409309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrinsic disorder of human Yin Yang 1 protein.
    Górecki A; Bonarek P; Górka AK; Figiel M; Wilamowski M; Dziedzicka-Wasylewska M
    Proteins; 2015 Jul; 83(7):1284-96. PubMed ID: 25963536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1.
    Verheul TCJ; van Hijfte L; Perenthaler E; Barakat TS
    Front Cell Dev Biol; 2020; 8():592164. PubMed ID: 33102493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.